NEFL and myeloid sarcoma: Biological evidence has suggested that underlying neuroaxonal damage and neurodegeneration may be evident at least 10 years before MS symptom onset, measurable as increases in serum neurofilament light chain (sNfL) levels.28 The observed rises in physician visits up to 14 years before MS symptom onset may reflect the lack of specificity of sNfL alone.